Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001404644-25-000101
Filing Date
2025-11-13
Accepted
2025-11-13 16:55:25
Documents
78
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ngne-20250930.htm   iXBRL 10-Q 1522255
2 EX-31.1 ngne-2025formq310xqxex311p.htm EX-31.1 9421
3 EX-31.2 ngne-2025formq310xqxex312p.htm EX-31.2 9552
4 EX-32.1 ngne-2025formq310xqxex321.htm EX-32.1 7170
10 ngne-20250930_g1.jpg GRAPHIC 81347
11 ngne-20250930_g2.jpg GRAPHIC 67114
12 ngne-20250930_g3.jpg GRAPHIC 57075
13 ngne-20250930_g4.jpg GRAPHIC 104483
  Complete submission text file 0001404644-25-000101.txt   7884318

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20250930.xsd EX-101.SCH 47489
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngne-20250930_cal.xml EX-101.CAL 56937
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngne-20250930_def.xml EX-101.DEF 212761
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20250930_lab.xml EX-101.LAB 628323
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20250930_pre.xml EX-101.PRE 432715
81 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20250930_htm.xml XML 906012
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 251479452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)